PROTECT: Rolofylline failed to improve renal function, CV outcomes - Cardiology Today |
|
|
Cardiology TodayThe experimental diuretic rolofylline failed to meet primary and secondary endpoints for the improvement of worsening renal function in patients with HF. ...
|